After finishing at $1.40 in the prior trading day, Precigen Inc (NASDAQ: PGEN) closed at $1.41, up 0.71%. In other words, the price has increased by $+0.0100 from its previous closing price. On the day, 646208 shares were traded. PGEN stock price reached its highest trading level at $1.4600 during the session, while it also had its lowest trading level at $1.4000.
Ratios:
Our goal is to gain a better understanding of PGEN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 2.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
On November 18, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $7.Cantor Fitzgerald initiated its Overweight rating on November 18, 2022, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 28 ’23 when KIRK RANDAL J bought 96,686 shares for $1.41 per share. The transaction valued at 136,327 led to the insider holds 1,096,686 shares of the business.
KINDLER JEFFREY B sold 96,686 shares of PGEN for $136,327 on Dec 28 ’23. The Director now owns 238,275 shares after completing the transaction at $1.41 per share. On Sep 22 ’23, another insider, MITCHELL DEAN J, who serves as the Director of the company, bought 25,000 shares for $1.41 each. As a result, the insider paid 35,250 and bolstered with 356,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PGEN now has a Market Capitalization of 353.47M and an Enterprise Value of 297.71M. For the stock, the TTM Price-to-Sale (P/S) ratio is 56.43 while its Price-to-Book (P/B) ratio in mrq is 2.96. Its current Enterprise Value per Revenue stands at 47.82 whereas that against EBITDA is -3.34.
Stock Price History:
Over the past 52 weeks, PGEN has reached a high of $1.88, while it has fallen to a 52-week low of $0.84. The 50-Day Moving Average of the stock is 1.4624, while the 200-Day Moving Average is calculated to be 1.3344.
Shares Statistics:
The stock has traded on average 1.09M shares per day over the past 3-months and 661.88k shares per day over the last 10 days, according to various share statistics. A total of 248.92M shares are outstanding, with a floating share count of 123.71M. Insiders hold about 50.30% of the company’s shares, while institutions hold 30.47% stake in the company. Shares short for PGEN as of Mar 15, 2024 were 16.91M with a Short Ratio of 15.44, compared to 17.54M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.79% and a Short% of Float of 11.45%.
Earnings Estimates
Its stock is currently analyzed by 5 different market analysts. On average, analysts expect EPS of -$0.09 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.09, while EPS last year was -$0.1. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.27 and -$0.37 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.27, with 5 analysts recommending between -$0.13 and -$0.42.
Revenue Estimates
Based on 5 analysts’ estimates, the company’s revenue will be $38.45M in the next fiscal year. The high estimate is $104.93M and the low estimate is $7M. The average revenue growth estimate for next year is up 596.60% from the average revenue estimate for this year.
